NEUROBLASTOMA RECURRENT
Clinical trials for NEUROBLASTOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA RECURRENT trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough childhood cancer: boosting immune attack on neuroblastoma
Disease control Recruiting nowThis study is testing whether adding an experimental immune-boosting drug called N-803 to a standard chemoimmunotherapy regimen works better for treating neuroblastoma that has returned or is not responding to prior therapy. It will involve about 54 children and young adults unde…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with tough cancers: Two-Drug attack enters trial
Disease control Recruiting nowThis study is testing a new oral drug, AMXT 1501, combined with an existing drug called DFMO, for children and young adults with aggressive cancers that have come back or didn't respond to standard treatments. The first part aims to find a safe dose, and the second part will comp…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Four-Pronged attack on tough childhood cancer
Disease control Recruiting nowThis study is testing a combination of four different immune-based treatments to see if they can help control neuroblastoma in children when the cancer has returned or not responded to standard therapies. The treatment involves donor immune cells, a targeted antibody, immune-boos…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE2 • Sponsor: Hong Kong Children's Hospital • Aim: Disease control
Last updated Feb 27, 2026 15:18 UTC